San-Miguel, J. F., Gutierrez, M.-A. E., Špicka, I., Mateos, M.-V., Song, K., Craig, M. D., Bladé, J., Hájek, R., Chen, C., Di Bacco, A., Estevam, J., Gupta, N., Byrne, C., Lu, V., van de Velde, H. and Lonial, S. (2018) “A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma”, Haematologica. Pavia, Italy, 103(9), pp. 1518-1526. doi: 10.3324/haematol.2017.185991.